CDKN1A and acute myeloid leukemia: Elevated endogenous levels of HES1 have been associated with longer relapse-free survival and increased overall survival in AML patients [84], and overexpression of HES1 in AML cell lines suppressed their growth and increased the expression of CDKN1A [85, 86].